MMI Highlights Commitment to Aesthetic Medicine at iSWAM 2024
- MMI
Tangerang, VIVA – The International Seminar and Workshop in Aesthetic Medicine (iSWAM) is taking place from December 6-8, 2024, at ICE BSD, Tangerang. As one of the world’s largest medical aesthetics conferences, the event draws over 20,000 attendees, including 5,000 doctors from 35 countries, 200 international speakers, and showcases 500 booths.
PT Mash Moshem Indonesia (MMI), a leading private label and contract manufacturing company for skincare, cosmetics, and personal care products, is proudly participating in this prestigious event at booth 37.
Elisabeth Novianita, Business Development Manager of MMI, emphasized the significance of iSWAM for the company’s growth. “This is an international lifestyle exhibition, and we aim to strengthen MMI’s branding as a producer of high-quality skincare and cosmetics,” she stated during the event.
MMI highlighted its commitment to delivering innovative, high-quality, and safe products that meet stringent safety requirements. “We prioritize consumer health and safety. All our products comply with certifications such as BPOM and HSA Singapore,” Novianita explained. Additionally, MMI’s Vegan USA certification ensures that its offerings cater to vegan lifestyles, free from animal-derived ingredients.
Beyond safety, MMI protects intellectual property through trademark registration and provides halal-certified products for customers with specific ethical preferences. To date, MMI has collaborated with over 1,723 brands, producing more than 6,157 BPOM-certified products.
At iSWAM 2024, MMI showcased tailored formulation services, packaging design, and regulatory support, aiming to empower doctors and entrepreneurs in launching innovative and safe aesthetic products. Visitors explored partnership opportunities and enjoyed exclusive offers, including free consultations, product samples, and promotional discounts of up to 90% on minimum order quantities.
“Our mission is to support doctors and entrepreneurs with products that are not only innovative and high-quality but also meet high safety standards,” Novianita noted.
MMI’s participation underscores its commitment to advancing the medical aesthetics industry. The company also plans to expand its presence to major cities like Yogyakarta, Balikpapan, Bandung, Surabaya, and Jakarta in 2025, offering more businesses access to top-tier private label and manufacturing services.
“Through this, we hope to help entrepreneurs access safe and high-quality manufacturing solutions,” Novianita concluded.
